Evaluation of short-term effectiveness of eight targeted agents combined with chemotherapy for treating esophageal-gastric junction adenocarcinoma: A network meta-analysis.

He, Yong-Ming; Yu, Chen; Li, Wei-Bing; Li, Zhi-Peng; Xu, Nan

He, Yong-Ming; Yu, Chen; Li, Wei-Bing; Li, Zhi-Peng; Xu, Nan.

Afiliación

He YM; Department of Integrated Traditional Chinese and Western Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China.
Yu C; Department of Integrated Traditional Chinese and Western Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China.
Li WB; Department of Integrated Traditional Chinese and Western Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China.
Li ZP; Department of Integrated Traditional Chinese and Western Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China.
Xu N; Department of Integrated Traditional Chinese and Western Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China.

J Cell Biochem ; 119(1): 1183-1192, 2018 01.

Article en En | MEDLINE | ID: mdl-28708307

Asunto(s)

Adenocarcinoma/tratamiento farmacológico; Anticuerpos Monoclonales/uso terapéutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Neoplasias Esofágicas/tratamiento farmacológico; Unión Esofagogástrica/patología; Adenocarcinoma/patología; Anticuerpos Monoclonales Humanizados/uso terapéutico; Bevacizumab/uso terapéutico; Cetuximab/uso terapéutico; Supervivencia sin Enfermedad; Quimioterapia; Neoplasias Esofágicas/patología; Humanos; Metaanálisis en Red; Panitumumab; Ensayos Clínicos Controlados Aleatorios como Asunto; Proteínas Recombinantes de Fusión/uso terapéutico; Trastuzumab/uso terapéutico; Resultado del Tratamiento; Ramucirumab

Palabras clave

chemotherapy; esophageal-gastric junction adenocarcinoma; placebo; randomized clinical trials; surface under the cumulative ranking curve; targeted agents

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Unión Esofagogástrica / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: J Cell Biochem Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google